Ascelia Pharma AB (publ) (STO:ACE)
2.810
+0.025 (0.90%)
Jun 12, 2026, 5:29 PM CET
Ascelia Pharma AB Cash Flow Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -70.9 | -76.25 | -80.03 | -109.29 | -131.22 | -125.9 |
Depreciation & Amortization | 0.89 | 0.89 | 0.94 | 1.05 | 1.05 | 1.03 |
Stock-Based Compensation | 3.42 | 4.16 | 4.34 | 2.93 | 1.63 | 5.92 |
Other Operating Activities | -0.34 | 0.99 | 8.38 | 0.35 | -11.38 | -11.08 |
Change in Accounts Receivable | 1.21 | 3.4 | -4.99 | 1.62 | -1.36 | -0.9 |
Change in Accounts Payable | -1.51 | -2.69 | 3.21 | -14.35 | 9.72 | 2.26 |
Change in Other Net Operating Assets | -3.96 | -2.75 | 5.31 | -9.11 | 6.31 | 12.11 |
Operating Cash Flow | -71.2 | -72.25 | -62.84 | -126.79 | -125.26 | -116.56 |
Capital Expenditures | -0.06 | -0.06 | - | - | - | -0.04 |
Other Investing Activities | - | - | - | 0.05 | -0.07 | - |
Investing Cash Flow | -0.06 | -0.06 | - | 0.05 | -0.07 | -0.04 |
Short-Term Debt Issued | - | - | 32.73 | - | - | - |
Long-Term Debt Issued | - | - | 0.73 | - | - | - |
Total Debt Issued | - | - | 33.46 | - | - | - |
Short-Term Debt Repaid | - | -20 | -7.5 | - | - | - |
Long-Term Debt Repaid | - | -0.81 | -0.89 | -0.91 | -1.02 | -0.94 |
Total Debt Repaid | -20.79 | -20.81 | -8.39 | -0.91 | -1.02 | -0.94 |
Net Debt Issued (Repaid) | -20.79 | -20.81 | 25.07 | -0.91 | -1.02 | -0.94 |
Issuance of Common Stock | 72.83 | 72.83 | 105.32 | - | 0.3 | 200.4 |
Repurchase of Common Stock | - | - | - | - | -0.3 | -0.4 |
Other Financing Activities | -3.81 | -3.81 | -15.21 | -0.03 | -0.08 | -14.19 |
Financing Cash Flow | 48.23 | 48.21 | 115.19 | -0.94 | -1.1 | 184.87 |
Foreign Exchange Rate Adjustments | -0.39 | -1.3 | 1.06 | -0.02 | 14.38 | 8.64 |
Miscellaneous Cash Flow Adjustments | 0 | - | - | -0 | - | - |
Net Cash Flow | -23.41 | -25.4 | 53.4 | -127.7 | -112.04 | 76.91 |
Free Cash Flow | -71.25 | -72.31 | -62.84 | -126.79 | -125.26 | -116.6 |
Free Cash Flow Per Share | -0.59 | -0.64 | -1.16 | -3.76 | -3.60 | -3.54 |
Cash Interest Paid | 0.82 | 1.74 | 5.22 | 0.12 | 0.05 | 0.08 |
Cash Income Tax Paid | - | -0.07 | -1.45 | -1.17 | -3.77 | -1.02 |
Levered Free Cash Flow | -62.8 | -63.09 | -16.1 | -87 | -74.73 | -74.23 |
Unlevered Free Cash Flow | -62.8 | -62.03 | -13.78 | -87 | -74.7 | -74.18 |
Change in Working Capital | -4.27 | -2.04 | 3.53 | -21.84 | 14.67 | 13.47 |